Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Research and Innovation Action · Running

POTENTIAL Platform Optimisation To Enable NanomaTerIAL safety assessment for rapid commercialisation

Coordinator
Istituto Di Ricerche Farmacologiche Mario Negri, Italy
Runs
1 January 2023 to 31 December 2026
Status
Running
EU funding
€3.0m
Total cost
€3.0m
Partners
12 organisations in 8 countries
Type
Research and Innovation Action
Grant agreement
101092901

What the project is doing

In the project's own words, from its summary on CORDIS.

Advanced Nanomaterials (Ad-NMs) will lead a new industrial revolution and accelerate the transition to greener technologies and better health care. However, lack of practical and reliable protocols to evaluate Ad-NMs' potential hazards and risks has hindered innovation so far. POTENTIAL will generate a methodological framework comprising a set of harmonised protocols for characterisation, testing, grouping and read-across of Ad-NMs, that meet regulatory requirements for risk assessment, by improving:a) Advanced imaging protocols to quantify and characterize the intrinsic and extrinsic properties of Ad-NMs in complex matrices, using conventional analytical methods. b) Protocols to trace the evolution of Ad-NMs properties throughout their lifecycle, and methodologies for accelerated testing. c) in vitro multi-cellular models, in vivo (invertebrate) models, and ecotoxicological models for assessing the environmental and health hazard of Ad-NMs.

Grouping and read-across approaches will build up on results from existing Horizon initiatives (GRACIOUS, SUNSHINE and HARMLESS), and will generate novel algorithms for similarity assessment, grouping hypotheses and Integrated Approaches to Testing and Assessments (IATAs). The protocols generated in the project will be validated through peer-reviewed publications and disseminated in Open Access. Furthermore, we will engage with the relevant standardisation bodies and organisations (OECD, ISO, CEN) to ensure that our approach can be translated into industry standards.

The consortium comprises 11 European partners and 1 international partner (China), among which 4 high-tech SMEs specialised in Ad-NMs, and a high-tech incubator / accelerator. POTENTIAL contributes to the Horizon Europe workprogram by helping establish appropriate methods for cost-efficient assessment and prediction of the health and environmental effects of Ad-NMs, as well as supporting the inclusion of new methods to support safe-and-sustainable-by-design.

Topics

Who is involved

OrganisationCityCountryRole
Istituto Di Ricerche Farmacologiche Mario NegriMilanoItalyCoordinator
East European Research and Innovation Enterprise LtdSofiaBulgariaParticipant
Zhejiang UniversityHangzhouChinaAssociatedpartner
Mybiotech GmbHUberherrnGermanyParticipant
Universitaet LeipzigLeipzigGermanyParticipant
Asociacion Centro De Investigacion Cooperativa En Biomateriales- Cic BiomaguneSan SebastianSpainParticipant
Graphenea SASan Sebastian GuipuzcoaSpainParticipant
Universite Paris 13VilletaneuseFranceParticipant
Royal College of Surgeons in IrelandDublin 2IrelandParticipant
Greendecision SRLVeneziaItalyParticipant
Innova SRLRomaItalyParticipant
Luxembourg Institute of Science and TechnologyEsch Sur AlzetteLuxembourgParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI